These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8911067)

  • 1. [Interaction between Epstein-Barr virus (EBV) gene expression and antibodies to EBV in nasopharyngeal carcinomas].
    Furukawa M; Nagayama I; Murono S; Takeshita H; Nishimura T; Yoshizaki T
    Rinsho Byori; 1996 Sep; 44(9):832-7. PubMed ID: 8911067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.
    Brousset P; Butet V; Chittal S; Selves J; Delsol G
    Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of Epstein-Barr virus genomes in nasopharyngeal carcinoma].
    Furukawa M; Murono S; Nakagawa S; Takeshita H; Yoshizaki T
    Nihon Rinsho; 1997 Feb; 55(2):346-9. PubMed ID: 9046821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
    Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
    Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
    Murono S; Yoshizaki T; Park CS; Furukawa M
    Histopathology; 1999 May; 34(5):432-8. PubMed ID: 10231418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas.
    Niedobitek G; Agathanggelou A; Barber P; Smallman LA; Jones EL; Young LS
    J Pathol; 1993 Aug; 170(4):457-61. PubMed ID: 8410495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
    Wang Y; Luo B; Zhao P; Huang BH
    Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
    Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
    Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of Bcl-2 oncoprotein in EBV-associated nasopharyngeal carcinoma correlated to histological type and survival.
    Vera-Sempere FJ; Burgos JS; Botella MS; Morera C
    Histol Histopathol; 1997 Jan; 12(1):9-18. PubMed ID: 9046038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
    Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
    Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus and carcinomas. Expression of the viral genome in an undifferentiated gastric carcinoma.
    Niedobitek G; Herbst H; Young LS; Rowe M; Dienemann D; Germer C; Stein H
    Diagn Mol Pathol; 1992 Jun; 1(2):103-8. PubMed ID: 1342957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas.
    Niedobitek G; Young LS; Sam CK; Brooks L; Prasad U; Rickinson AB
    Am J Pathol; 1992 Apr; 140(4):879-87. PubMed ID: 1314028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
    J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
    Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
    Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
    Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
    Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
    Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan.
    Wang LS; Chow KC; Wu YC; Li WY; Huang MH
    Am J Gastroenterol; 1999 Oct; 94(10):2834-9. PubMed ID: 10520830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
    Sheu LF; Chen A; Lee HS; Hsu HY; Yu DS
    Pathol Int; 2004 Jul; 54(7):475-85. PubMed ID: 15189500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.